Award
Delivery Order #SPE2DR26FCRZ4
Delivery Order for STELARA Pharmaceutical Product to Support Health Initiatives
Buyer
Defense Logistics Agency
Award Amount
$33,168.26
Ceiling
$33,168.26
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Mar 05, 2026
Identifier
SPE2DR26FCRZ4
NAICS
424210
This award represents a delivery order contract issued to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution and healthcare solutions. The order involves the procurement of the pharmaceutical product STELARA 90 MG/ML syringes, which are critical for treating various medical conditions. This contract is significant as it ensures timely access to essential medications, supporting ongoing health initiatives and contributing to public health outcomes. The scope of work includes the delivery of this specific pharmaceutical product to the designated place of performance in Park Ridge, Illinois. The contract was awarded as part of an existing indefinite delivery vehicle held by DMS Pharmaceutical Group, indicating a competitive and established procurement pathway. The delivery order covers a short-term period in early 2026, reflecting a focused and specific procurement action under the broader long-term agreement with an extensive performance period. No key subcontractors or additional solicitation details are provided for this award.
Description
4570852906!STELARA 90 MG/ML SYRINGEML